CytomX Therapeutics, Inc. Consulting Agreements
7 Contracts & Agreements
- Consulting Agreement effective as of September 13, 2022, by and between CytomX Therapeutics, Inc. and Amy C. Peterson, M.D (Filed With SEC on November 8, 2022)
- Consulting Agreement effective as of October 1, 2022, by and between CytomX Therapeutics, Inc. and Carlos Campoy (Filed With SEC on November 8, 2022)
- Consulting Agreement, effective as of April 1, 2021, by and between CytomX Therapeutics, Inc. and Dr. Charles Fuchs (Filed With SEC on May 6, 2021)
- Consulting Agreement effective as of December 14, 2020, by and between CytomX Therapeutics, Inc and Dr. W. Michael Kavanaugh (Filed With SEC on February 24, 2021)
- Consulting Agreement effective as of August 19, 2019, by and between CytomX Therapeutics, Inc. and Rachel W. Humphrey, M.D (Filed With SEC on November 7, 2019)
- Consulting Agreement effective as of May 15, 2019, by and between CytomX Therapeutics, Inc. and Debanjan Ray (Filed With SEC on May 9, 2019)
- Consulting Agreement between CytomX Therapeutics, Inc and Dr. Hoyoung Huh, effective as of December 30, 2018 (Filed With SEC on February 27, 2019)
